PARIS TURNER: Open Payments
NPI 1891108981 · CLARKSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 26 payments from 11 companies in 2025. Trend: 2023 $447 · 2024 $0 · 2025 $545
Food & beverage: $520Education: $25
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| ABBVIE INC. | 3 | $49 |
| Braeburn Inc. | 3 | $49 |
| Indivior Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
Products named: LYBALVI, CAPLYTA, ARISTADA, VRAYLAR, BRIXADI, VIVITROL, SUBLOCADE, Qelbree.
Industry payments across WV — which companies pay providers there.
